Data Insights
No Filter Selected
No Filter Selected
No Filter Selected
No Filter Selected
Ulixertinib by BioMed Valley Discoveries for Hematological Tumor: Likelihood of Approval
Ulixertinib is under clinical development by BioMed Valley Discoveries and currently in Phase II for Hematological Tumor. According to GlobalData,...
Ulixertinib by BioMed Valley Discoveries for Colorectal Cancer: Likelihood of Approval
Ulixertinib is under clinical development by BioMed Valley Discoveries and currently in Phase II for Colorectal Cancer. According to GlobalData,...
Ulixertinib by BioMed Valley Discoveries for Neurofibromatoses Type I (Von Recklinghausen's Disease): Likelihood of Approval
Ulixertinib is under clinical development by BioMed Valley Discoveries and currently in Phase I for Neurofibromatoses Type I (Von Recklinghausen's...